Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Caroline Quillent is active.

Publication


Featured researches published by Caroline Quillent.


The Lancet | 1998

HIV-1-resistance phenotype conferred by combination of two separate inherited mutations of CCR5 gene

Caroline Quillent; Estelle Oberlin; Joséphine Braun; Dominique Rousset; Gustavo Gonzalez-Canali; Patricia Métais; Luc Montagnier; Jean-Louis Virelizier; Fernando Arenzana-Seisdedos; Alberto Beretta

BACKGROUND Despite multiple exposures to HIV-1, some individuals remain uninfected, and their peripheral-blood mononuclear cells (PBMC) are resistant to in-vitro infection by primary HIV-1 isolates. Such resistance has been associated with a homozygous 32-base-pair deletion (delta 32) in the C-C chemokine receptor gene CCR5. We examined other mutations of the CCR5 gene that could be associated with resistance to HIV-1 infection. METHODS We assessed the susceptibility of PBMC to in-vitro infection by HIV-1 isolates that use the CCR5 as the major coreceptor for viral entry in 18 men who had frequent unprotected sexual intercourse with a seropositive partner. We also did genotypic analysis of CCR5 alleles. One of the 18 exposed but uninfected men (who we refer to as ExU2) showed total resistance to in-vitro infection by CCR5-dependent viruses, and was found to carry a CCR5 delta 32 allele and a single point mutation (T-->A) at position 303 on the other allele. To find out whether the CCR5 mutation was restricted to ExU2s family or existed in the general population, we did genetic analyses of the CCR5 genotype in ExU2s father and sister and also in 209 healthy blood donors who were not exposed to HIV-1. FINDINGS The m303 mutation found in ExU2 introduced a premature stop codon and prevented the expression of a functional coreceptor. The family studies revealed that the m303 mutant allele was inherited as a single mendelian trait. Genotype analysis showed that three of the 209 healthy blood donors were heterozygous for the mutant allele. INTERPRETATION We characterise a new CCR5 gene mutation, present in the general population, that prevents expression of functional coreceptors from the abnormal allele and confers resistance to HIV-1 infection when associated to the delta 32 CCR5 mutant gene.


AIDS | 1999

Enhanced HIV infectivity and changes in GP120 conformation associated with viral incorporation of human leucocyte antigen class I molecules.

Antonio Cosma; Dominique Blanc; Joséphine Braun; Caroline Quillent; Claudia Barassi; Christiane Moog; Sandrine Klasen; Bruno Spire; Gabriella Scarlatti; Elena Pesenti; Antonio G. Siccardi; Alberto Beretta

BACKGROUND Assembly of human immunodeficiency virus type 1 (HIV-1) occurs at the level of the plasma membrane of the host cell. During this process HIV incorporates significant quantities of cell surface-derived molecules into its lipid bilayer including human leucocyte antigen (HLA) class I and II, intercellular adhesion molecule-1 and lymphocyte function antigen-1. Several studies indicate that virion-bound host-cell-derived molecules are functional and affect the biological properties of HIV-1. Virion-associated HLA class II and intercellular adhesion molecule-1 enhance the infectivity of T-cell line-adapted (TCLA) viruses. No role for virion-associated HLA class I molecules has yet been identified. OBJECTIVE To investigate the role of HLA class I molecules in HIV replication and infectivity. METHODS HLA class I negative human cells lines transfected with the HLA Cw4 gene were infected with different TCLA viruses as well as primary X4 isolates. The infectivity of HLA Cw4 positive and negative viruses was determined on indicator cell lines and on phytohaemagglutinin-activated peripheral blood mononuclear cells. An entry polymerase chain reaction assay was used to determine differences in entry-competence of Cw4 positive and negative viruses. The expression of selected gp120 epitopes on native Env molecules derived from Cw4 positive and negative viruses was determined by a monoclonal antibody-based enzyme-linked immunosorbent assay. Immunoprecipitation experiments were performed to investigate the presence of gp120/HLA Cw4 complexes. Neutralization assays determined the differences in susceptibility to neutralization between HLA Cw4 negative and positive viruses. RESULTS AND CONCLUSIONS The infectivity of primary HIV-1 X4 isolates and of TCLA viruses is increased upon viral incorporation of HLA Cw4 molecules. This effect is associated with changes in viral envelope proteins conformation including an enhanced expression of the V3 loop of gp120, and of epitopes that are exposed upon CD4 binding. The gp120 conformational changes are consistent with the formation of a multimolecular complex between HLA class I and gp120/160. HLA Cw4 incorporation is also associated to a lower susceptibility to antibody neutralization. These findings have important implications for understanding the immune response to cryptic and conformational epitopes of the viral envelope.


Virology | 1994

ISOLATION AND ENVELOPE SEQUENCE OF A HIGHLY DIVERGENT HIV-1 ISOLATE : DEFINITION OF A NEW HIV-1 GROUP

Pierre Charneau; Andrew M. Borman; Caroline Quillent; Denise Guetard; Sophie Chamaret; Jacques H. M. Cohen; Gérard Rémy; Luc Montagnier; François Clavel


Virology | 1996

Extensive Regions ofpolAre Required for Efficient Human Immunodeficiency Virus Polyprotein Processing and Particle Maturation

Caroline Quillent; Andrew M. Borman; Sylvie Paulous; Charles Dauguet; Francois Clavel


Virology | 1995

A Highly Defective HIV-1 Group O Provirus: Evidence for the Role of Local Sequence Determinants in G → A Hypermutation during Negative-Strand Viral DNA Synthesis

Andrew M. Borman; Caroline Quillent; Pierre Charneau; Katherine M. Kean; François Clavel


Archive | 1995

Nucleotide sequences of HIV-1 type (or subtype) O retrovirus antigens

Pierre Charneau; Francois Clavel; Andrew M. Borman; Caroline Quillent; Denise Guetard; Luc Montagnier; Jacqueline Donjon De Saint-Martin; Jacques H. M. Cohen


Archive | 1998

Human immunodeficiency virus co-receptor variants associated with resistance to virus infection

Alberto Beretta; Caroline Quillent; Fernando Arenzana Siesdedos; Joséphine Braun


Archive | 2006

Nucleotide sequences of HIV-1 group (or subgroup) O retroviral antigens

Pierre Charneau; Francois Clavel; Andrew M. Borman; Caroline Quillent; Denise Guetard; Luc Montagnier; Jacqueline Donjon De Saint-Martin; Jacques H. M. Cohen


AIDS Research and Human Retroviruses | 1993

Reversion of a Polymerase-Defective Integrated HIV-1 Genome

Caroline Quillent; Nicolas Dumey; Charles Dauguet; François Clavel


AIDS Research and Human Retroviruses | 1994

Inhibition of HIV type 1 reverse transcriptase assay by nucleases produced by contaminating mycoplasmas

Caroline Quillent; Odile Grau; François Clavel; Luc Montagnier; Alain Blanchard

Collaboration


Dive into the Caroline Quillent's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge